Total Payments
$3,956
2020 Payments
$92.80
Companies
23
Transactions
399
Medicare Patients
4,500
Medicare Billing
$642,065
Payment Breakdown by Category
Food & Beverage$3,940 (99.6%)
Education$15.90 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,940 | 397 | 99.6% |
| Education | $15.90 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $688.39 | 41 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $640.60 | 93 | $0 (2019) |
| Gilead Sciences, Inc. | $534.27 | 61 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $497.11 | 66 | $0 (2020) |
| Amarin Pharma Inc. | $362.96 | 23 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $265.21 | 22 | $0 (2019) |
| PFIZER INC. | $161.32 | 11 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $151.30 | 19 | $0 (2019) |
| Aralez Pharmaceuticals US Inc. | $114.33 | 27 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $109.53 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $92.80 | 5 | Amgen Inc. ($47.02) |
| 2019 | $1,045 | 79 | Amgen Inc. ($237.24) |
| 2018 | $1,134 | 104 | Novartis Pharmaceuticals Corporation ($328.22) |
| 2017 | $1,684 | 211 | Gilead Sciences Inc ($497.59) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2020 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/13/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Cardiology | ||||||
| 01/30/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiology | ||||||
| 01/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: DIABETES | ||||||
| 01/22/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Cardiovascular | ||||||
| 12/19/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Cardiology | ||||||
| 12/19/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: DIABETES | ||||||
| 11/27/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: DIABETES | ||||||
| 11/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: DIABETES | ||||||
| 11/12/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology | ||||||
| 10/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: DIABETES | ||||||
| 10/02/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 31 | 4,500 | 5,907 | $1.7M | $642,065 |
Total Patients
4,500
Total Services
5,907
Medicare Billing
$642,065
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2020 | 212 | 212 | $631,548 | $247,106 | 39.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 605 | 617 | $268,395 | $95,153 | 35.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 897 | 1,070 | $241,820 | $80,570 | 33.3% |
| 93229 | Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2020 | 104 | 104 | $154,128 | $60,682 | 39.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2020 | 213 | 216 | $28,968 | $22,330 | 77.1% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 277 | 278 | $51,708 | $17,784 | 34.4% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 110 | 110 | $46,200 | $16,969 | 36.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 84 | 344 | $19,852 | $15,358 | 77.4% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 249 | 256 | $37,888 | $14,696 | 38.8% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2020 | 38 | 38 | $38,038 | $14,334 | 37.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 707 | 813 | $29,268 | $10,279 | 35.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 69 | 79 | $24,016 | $7,759 | 32.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 92 | 94 | $11,364 | $4,697 | 41.3% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 20 | 129 | $11,094 | $4,346 | 39.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2020 | 39 | 39 | $4,878 | $3,850 | 78.9% |
| 93289 | Evaluation of defibrillator including connection, recording and disconnection | Office | 2020 | 41 | 59 | $8,142 | $2,899 | 35.6% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2020 | 17 | 18 | $7,790 | $2,885 | 37.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 26 | 26 | $8,892 | $2,761 | 31.1% |
| 78472 | Nuclear medicine study of heart wall motion at rest or stress with evaluation of blood ejection from heart, single study | Office | 2020 | 13 | 13 | $6,305 | $2,351 | 37.3% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2020 | 101 | 101 | $5,656 | $2,279 | 40.3% |
| 93288 | Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report | Office | 2020 | 47 | 61 | $6,283 | $2,252 | 35.8% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2020 | 11 | 11 | $2,717 | $1,671 | 61.5% |
| A9560 | Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries | Office | 2020 | 14 | 14 | $2,440 | $1,660 | 68.0% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 27 | 34 | $5,100 | $1,585 | 31.1% |
| J1245 | Injection, dipyridamole, per 10 mg | Office | 2020 | 164 | 836 | $1,676 | $1,294 | 77.2% |
About Dr. John Vitarello, M.D
Dr. John Vitarello, M.D is a Cardiovascular Disease healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609879329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Vitarello, M.D has received a total of $3,956 in payments from pharmaceutical and medical device companies, with $92.80 received in 2020. These payments were reported across 399 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,940).
As a Medicare-enrolled provider, Vitarello has provided services to 4,500 Medicare beneficiaries, totaling 5,907 services with total Medicare billing of $642,065. Data is available for 1 year (2020–2020), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Frederick, MD
- Active Since 05/27/2005
- Last Updated 12/18/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1609879329
Products in Payments
- ENTRESTO (Drug) $640.60
- Vascepa (Drug) $362.96
- Repatha (Biological) $344.83
- Corlanor (Drug) $333.56
- PRADAXA (Drug) $278.76
- JARDIANCE (Drug) $215.64
- PRALUENT ALIROCUMAB INJECTION (Biological) $190.85
- ELIQUIS (Drug) $182.44
- PRALUENT (Drug) $132.18
- XARELTO (Drug) $109.53
- BRILINTA (Drug) $83.15
- PRALUENT (Biological) $74.36
- YOSPRALA (Drug) $67.35
- Welchol (Drug) $47.42
- ZONTIVITY (Drug) $46.98
- Reveal LINQ (Device) $42.05
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $38.99
- Ranexa (Drug) $36.68
- LifeVest (Device) $32.68
- TEGSEDI (Drug) $25.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Frederick
Dr. Stephen Williams, M.d., M.p.h, M.D., M.P.H
Cardiovascular Disease — Payments: $71,640
Cardiovascular Disease $71,640
Kusay Barakat, M.d, M.D
Cardiovascular Disease — Payments: $19,947
Cardiovascular Disease $19,947
Chen Tung, Md, MD
Cardiovascular Disease — Payments: $7,376
Cardiovascular Disease $7,376
Shawn Buki, Md, MD
Cardiovascular Disease — Payments: $5,874
Cardiovascular Disease $5,874
Dr. Samir Ahuja, M.d, M.D
Cardiovascular Disease — Payments: $4,749
Cardiovascular Disease $4,749
David Yu, M.d, M.D
Cardiovascular Disease — Payments: $3,797
Cardiovascular Disease $3,797